Search Awardees

Recombinant Technologies LogoRecombinant Technologies

UEI: LC6JYTFEJ5N1 • CAGE: 458Z3

Overview

Awardee Type
Parent
Company Description
Recombtech, Amytrap, AmyTrap in Action, Cure for Alzheimer's Disease, A Unique Treatment for Alzheimer's Disease. Alzheimer's, Recombtech Technologies, Dr.Pazhani Sundaram. what is amytrap, safely treating Alzheimer's Disease. Amytrap technology. Yale, Yale School of Medicine, Sundaram's research, clinical trial, India to treat coronary heart disease. Alzheimer's disease drug development. Treatment for Alzheimer's Disease, small molecules, RTL's current focus is on developing small molecules Developing Therapeutics, Innovative Technology, For better future.
Name
Recombinant Technologies
Headquarters
Cheshire, CT
United States
Federal grant recipient RECOMBINANT TECHNOLOGIES LLC (UEI LC6JYTFEJ5N1, CAGE 458Z3) is headquartered in Cheshire CT. Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The organization was founded in May 1998 and federally registered in September 2005.

Federal Award Analysis

Recombinant Technologies federal award history

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating

Federal Registration and Certifications

Legal Name
RECOMBINANT TECHNOLOGIES LLC
Division Name
RECOMBINANT TECHNOLOGIES
Division Number
RECOMBINAN
UEI
LC6JYTFEJ5N1
CAGE Code
458Z3
SBA Certifications
None
Self Certifications
Minority Owned Business
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Entity Structure
Other

People

Vendor contacts at Recombinant Technologies

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo

Grant Awards

Recombinant Technologies direct grants